Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(18)30071-8
PubMed Identifier: 29655877
Publication URI: http://europepmc.org/abstract/MED/29655877
Type: Journal Article/Review
Volume: 6
Parent Publication: The lancet. Diabetes & endocrinology
Issue: 6
ISSN: 2213-8587